Booster of the "More Time for Patients" Program

July 3, 2024 updated by: Thomas Agoritsas, University Hospital, Geneva

Booster of the "More Time for Patients" Program: a Cluster Randomized Controlled Trial

The goal of this clinical trial is to determine if reactivating a hospital program called "Plus de temps au service des patients" (PTP) can improve the quality of pain management for patients and increase job satisfaction among healthcare professionals. The main questions this study aims to answer are:

  • Does reactivating PTP improve the quality of pain management?
  • Does reactivating PTP increase healthcare professionals' job satisfaction? In this study, researchers will compare the effects of reactivating the program immediately to reactivating it after a 3-month delay.

Participants in the trial are healthcare professionals who will:

  • Select 2 or 3 elements of the program they believe would be most beneficial to reactivate in their hospital units.
  • Implement the selected elements for 3 months.
  • Complete job satisfaction and burnout questionnaires before and after the study.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

764

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Geneva, Switzerland, 1205
        • Geneva University Hospitals
        • Contact:
        • Contact:
        • Principal Investigator:
          • Thomas Agoritsas, MD,PhD
        • Principal Investigator:
          • Delphine S. Courvoisier, PhD
        • Sub-Investigator:
          • Clement P. Buclin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria for the units:

  • Implementation of PTP finished at least 6 months previously
  • Agreement to the study from both medical head of service and head of unit (IRES)

Inclusion criteria for healthcare professionals:

  • Healthcare professionals >18 yo.
  • Healthcare professionals working in a HUG service of medicine or surgery.
  • Healthcare professionals include Physicians, Nurses, Assistant Nurses, Pharmacists, Physiotherapists and other physical therapists.
  • Provided general informed consent.

Inclusion criteria for patients

  • Patients hospitalised in one of the boosted units.
  • Cognitive ability to provide satisfaction assessment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediate reactivation
Our intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months
Our intervention will be booster measure of the existing PTP elements that will be designed for each unit that has been randomized to the immediate intervention group. The booster will consist in a reactivation through audit and feedback of 2-3 elements of the PTP program. The selection of the elements to boost will be done locally in each unit through a coordinated discussion between representants of the PTP organization and representants of the unit's medical and nursing professionals. This will create an adaptable intervention that will feature selected standards among the list of 36 existing standards. The boost will be performed over 3 months
No Intervention: Delayed reactivation
The control intervention will also be PTP as applied usually, in the control group before the application of the booster measure (applied delayed by three months).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timely delivery of appropriate analgesic
Time Frame: Timely is operationalized as maximum 6 hours before for reserve pain medication, and up to 1 hour after pain measurement for any medication appropriate to the level of pain.
Quality of pain management as recorded through the timely delivery of an appropriate level painkiller after any pain Visual Analog Scale (VAS) ≥4. VAS score range from 0 to 10, 0 being no pain and 10 being the worse pain imaginable.
Timely is operationalized as maximum 6 hours before for reserve pain medication, and up to 1 hour after pain measurement for any medication appropriate to the level of pain.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain VAS documentation
Time Frame: 12 hours
Patients stay will be divided in 12 hours segments and documentation will be considered adequate when 90% of the segments have at least 1 pain Visual Analog Scale score documented. VAS score range from 0 to 10, 0 being no pain and 10 being the worse pain imaginable.
12 hours
Patient satisfaction - Picker
Time Frame: 1 week after discharge for every patients.
Patient satisfaction is already routinely collected via continuous Picker satisfaction questionnaires. They are sent one week after patient discharge to all patients with a valid email address.
1 week after discharge for every patients.
Patient satisfaction - daily
Time Frame: Every day from month 1 to month 3 corresponding to the period of study
Daily patient satisfaction is already routinely collected in a 3 level scale going from 1 dissatisfied to 3 fully satisfied. Surveys are realized at the bedside, often by nurse assistant in the early afternoon.
Every day from month 1 to month 3 corresponding to the period of study
Healthcare professionals' satisfaction
Time Frame: Once before the reactivation and once after (month 1 and month 3)
Healthcare professionals' satisfaction will be evaluated using the satisfaction with work scale. All item range from extremely dissatisfied to extremely satisfied.
Once before the reactivation and once after (month 1 and month 3)
Healthcare professionals' burnout
Time Frame: Once before the reactivation and once after (month 1 and month 3)
Burnout will be assessed using the Copenhagen burnout inventory. The Copenhagen Burnout Inventory is a three dimensions scale evaluating the personal, the professional and the relational components of burnout. Each dimension is scored on a scale ranging from 0 to 100, 0 being no burnout and 100 being the maximum burnout.
Once before the reactivation and once after (month 1 and month 3)
Healthcare professionals' risk of turnover
Time Frame: Once before the reactivation and once after (month 1 and month 3)
Risk of turnover will be investigated by the following validated single item "If it were possible and you would keep a similar salary, would you like to change profession to take up another one or to keep the same profession but without patient care?" Three answers are possible: "No, I do not want to", "Perhaps", and "Yes, I do want to"
Once before the reactivation and once after (month 1 and month 3)
Healthcare professional's absenteeism rate
Time Frame: At month 1, 2 and 3 corresponding to the period of study
If given consent by the participants, individual monthly absenteeism rate will be extracted from the human resources of the hospital. For all others, absenteeism rate will be extracted aggergated at the unit level.
At month 1, 2 and 3 corresponding to the period of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Agoritsas, MD, PhD, University Hospital, Geneva
  • Principal Investigator: Delphine S. Courvoisier, PhD, University Hospital, Geneva

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2024

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

October 1, 2025

Study Registration Dates

First Submitted

June 6, 2024

First Submitted That Met QC Criteria

July 3, 2024

First Posted (Actual)

July 9, 2024

Study Record Updates

Last Update Posted (Actual)

July 9, 2024

Last Update Submitted That Met QC Criteria

July 3, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clinical Encounter Quality

Clinical Trials on Immediate reactivation

Subscribe